Inventor
ANANDAN PALANI
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes22%
C07KPeptides15%
C07BGeneral methods of organic chemistry11%
C07DHeterocyclic compounds11%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium11%
PatentTitleYear
12,297,208Small molecule inhibitors of KRAS G12C mutant202512,291,538Small molecule inhibitors of KRAS G12C mutant202512,240,867Arginase inhibitors and methods of use202512,215,116Arginase inhibitors and methods of use202511,697,657Small molecule inhibitors of KRAS G12C mutant202311,566,057Long-acting co-agonists of the glucagon and GLP-1 receptors202311,492,385Long-acting co-agonists of the glucagon and GLP-1 receptors202211,274,111Arginase inhibitors and methods of use2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to MERCK SHARP & DOHME LLC (7)· patent assignee history
2022–2023Patents assigned to MERCK SHARP & DOHME (3)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME LLC | 7 | 2022–2025 |
| MERCK SHARP & DOHME | 3 | 2022–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2025 |